Palvella Therapeutics, Inc. (PVLA)

NASDAQ: PVLA · Real-Time Price · USD

157.77

+2.84 (1.83%)

Aug 7, 2026, 4:00 PM EDT - Market closed

Palvella Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2016
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '16 Dec 31, 2016
Net Income	-61.7	-41.72	-17.43	18.69	-33.28	-22.8
Depreciation & Amortization	-	-	-	-	2.78	0.36
Stock-Based Compensation	12.41	6.4	0.83	0.6	4.4	1.91
Other Adjustments	10.62	6.49	5.96	-29.85	-0.47	0.05
Change in Receivables	-	2.49	-1.98	-	-2.62	-0.06
Changes in Accounts Payable	3.46	1.26	2.24	-2.25	-4.21	1.36
Changes in Accrued Expenses	-0.71	-1.3	1.05	-1.18	-4.01	2.06
Changes in Unearned Revenue	-	-	-	-	-20.19	3.75
Changes in Other Operating Activities	-1.52	1.36	-1.5	0.27	-2.35	-1.02
Operating Cash Flow	-36.51	-25.01	-10.84	-13.7	-59.93	-14.39
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2016
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '16 Dec 31, 2016
Capital Expenditures	-	-	-	-	-1.04	-0.58
Sale of Property, Plant & Equipment	-	-	-	-	-	0.02
Purchases of Investments	-70.47	-	-	-	-48.4	-
Proceeds from Sale of Investments	-	-	-	-	28.2	-
Investing Cash Flow	-62.47	-	-	-	-21.24	-0.56

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2016
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '16 Dec 31, 2016
Long-Term Debt Issued	-	-	18.43	-	-	-
Net Long-Term Debt Issued (Repaid)	-	-	18.43	-	-	-
Issuance of Common Stock	232.58	0.76	-	-	7.21	-
Net Common Stock Issued (Repurchased)	232.58	0.76	-	-	7.21	-
Other Financing Activities	-17.49	-1.42	68.66	5	-	15.22
Financing Cash Flow	216.2	-0.66	87.09	5	7.21	15.22

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2016
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '16 Dec 31, 2016
Foreign Exchange Rate Adjustments	0.15	0.05	0	-	-5.18	-0.27
Net Cash Flow	117.37	-25.62	76.25	-8.7	-79.13	6.4

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2016
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '16 Dec 31, 2016
Free Cash Flow	-36.51	-25.01	-10.84	-13.7	-60.97	-14.97
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-2.90	-2.22	-4.87	-7.64	-33.99	-28.71
Levered Free Cash Flow	-10.12	-40.39	2.78	14.77	-62.28	-16.86
Unlevered Free Cash Flow	-56.51	-37.28	-12.31	-15.02	-98.38	-22.49

SEC Filings: 10-K · 10-Q